奥泰生物 (688606.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(奥泰生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 172,091,295.89151,711,957.82236,135,335.17378,501,815.29286,536,646.03624,612,612.612,098,917,066.48
 营业收入(元) 172,091,295.89151,711,957.82236,135,335.17378,501,815.29286,536,646.03624,612,612.612,098,917,066.48
二、营业总成本(元) 131,943,848.93126,981,654.51178,928,268.65346,603,983.54248,511,909.20366,983,694.66788,203,105.26
 营业成本(元) 84,560,017.9795,410,611.34111,691,152.72275,854,677.76152,042,494.60255,322,301.49674,486,872.90
 研发费用(元) 23,814,423.2629,756,834.7636,121,641.2147,918,782.9859,443,120.3653,094,244.0046,841,374.33
 营业税金及附加(元) 1,106,529.001,003,975.461,591,444.707,489,040.285,958,960.3512,698,859.391,674,748.42
 销售费用(元) 14,805,769.4915,968,514.0516,674,929.8717,881,775.6929,474,666.1860,317,663.7742,667,201.09
 管理费用(元) 13,988,811.3216,293,784.3118,170,533.2112,768,629.3526,309,972.6618,632,349.4920,351,972.68
 财务费用(元) -6,331,702.11-31,452,065.42-5,321,433.05-15,308,922.52-24,717,304.95-33,081,723.482,180,935.84
  其中:利息费用(元) 334,541.80391,284.66442,378.79373,373.25569,323.90473,030.60755,672.66
  其中:利息收入(元) 7,689,680.3413,348,603.448,449,126.9910,396,305.6916,683,702.8311,672,744.834,133,600.46
 资产减值损失(元) -3,725,108.3321,840,649.60-17,060,829.32-208,982,285.25---71,081,892.35
 信用减值损失(元) -3,344,510.67-2,958,760.98-7,808,310.941,369,161.15-678,310.50-2,033,681.39-4,213,805.80
三、其他经营收益
 加:公允价值变动收益(元) 3,552,303.76-8,117,924.189,527,403.11-44,846,223.8514,618,018.63--
 加:投资收益(元) 79,563.121,605,108.254,659,569.009,666,885.742,096,882.679,478,239.922,876,561.30
 资产处置收益(元) -311,384.93-846,551.64517,141.6116,140.84--109.23
 其他收益(元) 1,316,287.977,410,391.10576,469.165,748,538.327,606,111.2214,427,774.383,968,247.34
 营业利润平衡项目(元) ---0.01----
四、营业利润(元) 38,025,982.8144,821,152.0446,254,815.88-204,628,950.5361,683,579.69294,510,804.291,242,262,962.48
 加:营业外收入(元) -13,132.77842.15-831,888.82674,046.42124,670.01158,345.76
 减:营业外支出(元) 325,193.0713,627,379.39200,109.352,750,639.23432,603.193,849,320.755,472,672.66
五、利润总额(元) 37,700,789.7431,206,905.4246,055,548.68-208,211,478.5861,925,022.92290,786,153.551,236,948,635.58
 减:所得税费用(元) 7,281,323.31716,180.515,719,419.35-32,499,118.234,000,860.4437,103,475.64187,827,420.18
六、净利润(元) 30,419,466.4330,490,724.9140,336,129.33-175,712,360.3557,924,162.48253,682,677.911,049,121,215.40
(一)按经营持续性分类
  持续经营净利润(元) 30,419,466.4330,490,724.9140,336,129.33-175,712,360.3557,924,162.48253,682,677.911,049,121,215.40
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 30,383,843.9830,649,350.0840,532,500.99-176,076,393.7757,837,519.39253,506,401.521,049,210,119.14
  少数股东损益(元) 35,622.45-158,625.17-196,371.66364,033.4286,643.09176,276.39-88,903.74
 扣除非经常性损益后的净利润(元) 26,459,823.3341,255,535.3528,875,915.88-147,830,011.6736,893,215.50223,535,566.651,047,901,207.44
七、每股收益
 一、基本每股收益(元) 0.380.150.75-3.271.074.7119.46
 二、稀释每股收益(元) 0.380.150.75----
八、其他综合收益(元) -874,674.365,039,229.71-280,655.17-655,156.5514,403,387.4714,285,973.5290,520.69
 归属于母公司股东的其他综合收益(元) -873,098.475,094,044.91-339,700.28-663,382.1014,417,174.7514,283,169.4393,324.78
 归属于少数股东的其他综合收益(元) -1,575.89-54,815.2059,045.118,225.55---2,804.09
九、综合收益总额(元) 29,544,792.0735,529,954.6240,055,474.16-176,367,516.9072,327,549.95267,968,651.431,049,211,736.09
 归属于母公司所有者的综合收益总额(元) 29,510,745.5135,743,394.9940,192,800.71-176,739,775.8772,254,694.14267,789,570.951,049,303,443.92
 归属于少数股东的综合收益总额(元) 34,046.56-213,440.37-137,326.55372,258.9772,855.81179,080.48-91,707.83
公告日期 2023-10-312023-08-292023-04-292023-04-292022-10-292022-08-262022-04-28
审计意见(境内) 标准无保留意见

前瞻产业研究院